These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.
    Author: Oppenheim B, Hefez A, Youdim MB.
    Journal: Prog Biochem Pharmacol; 1980; 16():119-32. PubMed ID: 7443729.
    Abstract:
    Human platelets are activated by epinephrine (E), norepinephrine (NE), ADP, and serotonin (5-HT) by a process that can be measured as cellular aggregation and at the completion of which 5-HT is released from storage vesicles. Among the three neurotransmitters, only the 5-HT response at its maximum concentration is transient (reversible), and in a given platelet preparation can be produced only once. This effect is highly specific. Structural analogues of 5-HT, such as tryptolines (TLNs) or 5-methoxy-N,N dimethyltryptamine (5-MNDTA), with agonist properties in animal behavioral models, cannot induce a 5-HT-like response in the platelet system; however, they competitively inhibit the platelet aggregation response (PAR) to 5-HT if preincubated with the platelets. Inhibition constants of TLNs for 5-HT and E are of an order of magnitude higher than the KM values for aggregation. A transient '5-HT-like' PAR can be produced by compounds structurally unrelated to 5-HT, such as the following: a preparation of adenylylimidodiphosphate (AIP) can cause a transient PAR similar to the 5-HT response with a KM of 0.2-0.5 mM. Experimental evidence suggests that this ATP analogue is also an inhibitor of the second phase of aggregation (17) and release of dense vesicle content, thereby exhibiting only a monophasic and transient PAR. A '5-HT-like' PAR can also be produced by a combination of E and ATP at concentrations at which neither by itself causes aggregation. These transient PARs may serve as tools to investigate the underlying mechanism of the self-restricted yet exhaustible ability of platelets to respond to the aggregation inducer. Drug-free schizophrenic patients having their first psychotic episode have a transient 5-HT PAR indistinguishable from that of control subjects. However, after 2-3 weeks on chlorpromazine (CPZ) as the sole neuroleptic, the patients defined as schizophrenic could be divided into 2 sub-groups: a) those who developed an enhanced and irreversible PAR to 5-HT and were reported as good clinical responders; and b) those whose transient 5-HT PAR remained unchanged for 10-12 weeks and were reported as slow, poor or non-responders. The study of the mechanism of the enhanced 5-HT PAR in CPZ-treated patients may contribute to the understanding of certain aspects of the mode of action of CPZ.
    [Abstract] [Full Text] [Related] [New Search]